IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Merck KGaA Confirms Generics Sale; Launches Merck Serono

1:38 PM MDT | January 17, 2007 | Alex Scott

Merck KGaA has confirmed that it is “evaluating the divestiture” of its Merck Generics generic drug division (CW, Jan. 3/10, p. 5). The company says it is in the early stages of planning to sell the generics business, and that it is “not engaged in initial discussions with any potential buyers.” Analysts say that the sale of the generics business could raise up to €4 billion ($5.3 billion). Private equity firms, rather than pharma manufacturers, are more likely to be interested in buying Merck Generics, analysts add. Ranbaxy, one of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa